Psychomotor performance after intake of zopiclone compared with intake of ethanol: A randomized, controlled, double-blinded trial

Journal of Clinical Psychopharmacology

Volumn 31, Issue 4, 2011, Pages 481-488

  Gustavsen, Ingebjørg ^a   Hjelmeland, Knut ^a,b   Bernard, Jean Paul ^a   Mørland, Jørg ^a,c  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

ethanol; impairment; psychomotor performance; zopiclone

Indexed keywords

ALCOHOL; PLACEBO; ZOPICLONE;

ALCOHOL BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; HUMAN; HUMAN EXPERIMENT; MALE; PRIORITY JOURNAL; PSYCHOMOTOR DISORDER; PSYCHOMOTOR PERFORMANCE; RANDOMIZED CONTROLLED TRIAL;

ADULT; AZABICYCLO COMPOUNDS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ETHANOL; HUMANS; MALE; PIPERAZINES; PSYCHOMOTOR PERFORMANCE; REACTION TIME; YOUNG ADULT;

EID: 79960616355     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3182214be6     Document Type: Article

References (31)

1. Hausken AM, Furu K, Skurtveit S, et al. Starting insomnia treatment: the use of benzodiazepines versus z-hypnotics. A prescription database study of predictors. Eur J Clin Pharmacol. 2008;65:295-301.
2. Kassam A, Carter B, Patten SB. Sedative hypnotic use in Alberta. Can J Psychiatry. 2006;51:287-294. (Pubitemid 43764711)
3. Ohayon MM, Caulet M, Arbus L, et al. Are prescribed medications effective in the treatment of insomnia complaints? J Psychosom Res. 1999;47:359-368.
4. Najib J. Eszopiclone, a nonbenzodiazepine sedative-hypnotic agent for the treatment of transient and chronic insomnia. Clin Ther. 2006;28: 491-516. (Pubitemid 44218955)
5. Gustavsen I, Al-Sammurraie M, Morland J, et al. Impairment related to blood drug concentrations of zopiclone and zolpidem compared to alcohol in apprehended drivers. Accid Anal Prev. 2009;41: 462-466.
6. Gustavsen I, Bramness JG, Skurtveit S, et al. Road traffic accident risk related to prescriptions of the hypnotics zopiclone, zolpidem, flunitrazepam and nitrazepam. Sleep Med. 2008;9:818-822.
7. Barbone F, McMahon AD, Davey PG, et al. Association of road-traffic accidents with benzodiazepine use. Lancet. 1998;352: 1331-1336. (Pubitemid 28510912)
8. Vermeeren A, Riedel WJ, van Boxtel MP, et al. Differential residual effects of zaleplon and zopiclone on actual driving: a comparison with a low dose of alcohol. Sleep. 2002;25:224-231. (Pubitemid 34193585)
9. Verster JC, Veldhuijzen DS, Volkerts ER. Residual effects of sleep medication on driving ability. Sleep Med Rev. 2004;8:309-325. (Pubitemid 38834209)
10. Kuitunen T, Mattila MJ, Seppala T. Actions and interactions of hypnotics on human performance: single doses of zopiclone, triazolam and alcohol. Int Clin Psychopharmacol. 1990;5(suppl 2):115-130.
11. Mattila MJ, Vanakoski J, Kalska H, et al. Effects of alcohol, zolpidem, and some other sedatives and hypnotics on human performance and memory. Pharmacol Biochem Behav. 1998;59:917-923. (Pubitemid 28237904)
12. Walsh JM, Verstraete AG, Huestis MA, et al. Guidelines for research on drugged driving. Addiction. 2008;103:1258-1268. (Pubitemid 352009056)
13. Christophersen AS, Morland J. Frequent detection of benzodiazepines in drugged drivers in Norway. Traffic Inj Prev. 2008;9:98-104.
14. Olsen V, Gustavsen I, Bramness JG, et al. The concentrations, appearance and taste of nine sedating drugs dissolved in four different beverages. Forensic Sci Int. 2005;151:171-175. (Pubitemid 40804472)
15. Mørland J, Seterkleiv J, Haffner JFW, et al. Combined effects of diazepam and ethanol on mental and psychomotor functions. Acta Pharmacol Toxicol. 1973;34:5-15.
16. Gjerde H, Oiestad EL, Langodegard M, et al. Comparison of zopiclone concentrations in oral fluid sampled with Intercept((R)) oral specimen collection device and Statsure Saliva Sampler and concentrations in blood. J Anal Toxicol. 2010;34:590-593.
17. Kristoffersen L, Stormyhr LE, Smith-Kielland A. Headspace gas chromatographic determination of ethanol: the use of factorial design to study effects of blood storage and headspace conditions on ethanol stability and acetaldehyde formation in whole blood and plasma. Forensic Sci Int. 2006;161:151-157. (Pubitemid 44142905)
18. Kristoffersen L, Smith-Kielland A. An automated alcohol dehydrogenase method for ethanol quantification in urine and whole blood. J Anal Toxicol. 2005;29:387-389. (Pubitemid 41191709)
19. Hegstad S, Oiestad EL, Johansen U, et al. Determination of benzodiazepines in human urine using solid-phase extraction and high-performance liquid chromatography-electrospray ionization tandem mass spectrometry. J Anal Toxicol. 2006;30:31-37. (Pubitemid 44270340)
20. Epstein JN, Erkanli A, Conners CK, et al. Relations between Continuous Performance Test performance measures and ADHD behaviors. J Abnorm Child Psychol. 2003;31:543-554. (Pubitemid 37229132)
21. Fernandez C, Martin C, Gimenez F, et al. Clinical pharmacokinetics of zopiclone. Clin Pharmacokinet. 1995;29:431-441. (Pubitemid 26004180)
22. Paton A. Alcohol in the body. BMJ. 2005;330:85-87.
23. Billiard M, Besset A, de Lustrac C, et al. Dose-response effects of zopiclone on night sleep and on nighttime and daytime functioning. Sleep. 1987;10(suppl 1):27-34.
24. Warot D, Bensimon G, Danjou P, et al. Comparative effects of zopiclone, triazolam and placebo on memory and psychomotor performance in healthy volunteers. Fundam Clin Pharmacol. 1987;1:145-152. (Pubitemid 17162353)
25. Griffiths AN, Jones DM, Richens A. Zopiclone produces effects on human performance similar to flurazepam, lormetazepam and triazolam. Br J Clin Pharmacol. 1986;21:647-653. (Pubitemid 16004852)
26. Paraskevaides T, Morgan CJ, Leitz JR, et al. Drinking and future thinking: acute effects of alcohol on prospective memory and future simulation. Psychopharmacology (Berl). 2010;208:301-308.
27. Deakin JB, Aitken MR, Dowson JH, et al. Diazepam produces disinhibitory cognitive effects in male volunteers. Psychopharmacology (Berl). 2004;173:88-97. (Pubitemid 38591151)
28. Vermeeren A. Residual effects of hypnotics: epidemiology and clinical implications. CNS Drugs. 2004;18:297-328. (Pubitemid 38526714)
29. Vuurman EF, Muntjewerff ND, Uiterwijk MM, et al. Effects of mefloquine alone and with alcohol on psychomotor and driving performance. Eur J Clin Pharmacol. 1996;50:475-482. (Pubitemid 26281067)
30. Ogden EJ, Moskowitz H. Effects of alcohol and other drugs on driver performance. Traffic Inj Prev. 2004;5:185-198. (Pubitemid 39049922)
31. Blomberg RD, Peck RC, Moskowitz H, et al. The Long Beach/Fort Lauderdale relative risk study. J Safety Res. 2009;40:285-292.